These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 23863722)
1. [Recent advances in gastroenteropancreatic neuroendocrine tumor pathology]. Sasano H; Kasajima A Gan To Kagaku Ryoho; 2013 Jul; 40(7):833-7. PubMed ID: 23863722 [TBL] [Abstract][Full Text] [Related]
2. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors. Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616 [TBL] [Abstract][Full Text] [Related]
3. Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report. Rindi G; Bordi C; La Rosa S; Solcia E; Delle Fave G; ; Dig Liver Dis; 2011 Mar; 43 Suppl 4():S356-60. PubMed ID: 21459341 [TBL] [Abstract][Full Text] [Related]
4. Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Rindi G; Klersy C; Inzani F; Fellegara G; Ampollini L; Ardizzoni A; Campanini N; Carbognani P; De Pas TM; Galetta D; Granone PL; Righi L; Rusca M; Spaggiari L; Tiseo M; Viale G; Volante M; Papotti M; Pelosi G Endocr Relat Cancer; 2014 Feb; 21(1):1-16. PubMed ID: 24344249 [TBL] [Abstract][Full Text] [Related]
5. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification. Yang Z; Tang LH; Klimstra DS Am J Surg Pathol; 2011 Jun; 35(6):853-60. PubMed ID: 21566513 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of diagnosing colorectal neuroendocrine carcinoma using the World Health Organization 2010 classification. Lee JL; Yu CS; Kim M; Hong SM; Lim SB; Kim JC Surgery; 2014 Apr; 155(4):650-8. PubMed ID: 24468036 [TBL] [Abstract][Full Text] [Related]
7. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Klöppel G Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112 [TBL] [Abstract][Full Text] [Related]
8. Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system - a review. Păun I; Becheanu G; Costin AI; Constantin VD; Mihai GM; Radu L; Iovan L; Vârcuş F Rom J Morphol Embryol; 2018; 59(3):673-678. PubMed ID: 30534804 [TBL] [Abstract][Full Text] [Related]
9. New model for gastroenteropancreatic large-cell neuroendocrine carcinoma: establishment of two clinically relevant cell lines. Krieg A; Mersch S; Boeck I; Dizdar L; Weihe E; Hilal Z; Krausch M; Möhlendick B; Topp SA; Piekorz RP; Huckenbeck W; Stoecklein NH; Anlauf M; Knoefel WT PLoS One; 2014; 9(2):e88713. PubMed ID: 24551139 [TBL] [Abstract][Full Text] [Related]
10. [The new WHO classification of digestive neuroendocrine tumors]. Scoazec JY; Couvelard A; Ann Pathol; 2011 Apr; 31(2):88-92. PubMed ID: 21601112 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms]. Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): a critical view. Fazio N; Spada F; Giovannini M Cancer Treat Rev; 2013 May; 39(3):270-4. PubMed ID: 22819619 [TBL] [Abstract][Full Text] [Related]
13. [The terminology, classifications and staging of neuroendocrine tumors of the pancreas]. Kubyshkin VA; Kochatkov AV; Konstantinova MM; Kriger AG Khirurgiia (Mosk); 2012; (6):4-8. PubMed ID: 22951606 [TBL] [Abstract][Full Text] [Related]
14. Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases. Volante M; Daniele L; Asioli S; Cassoni P; Comino A; Coverlizza S; De Giuli P; Fava C; Manini C; Berruti A; Papotti M Am J Surg Pathol; 2013 Apr; 37(4):606-12. PubMed ID: 23426123 [TBL] [Abstract][Full Text] [Related]
15. Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future. Ohmoto A; Rokutan H; Yachida S Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098761 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. Matsui K; Jin XM; Kitagawa M; Miwa A Arch Pathol Lab Med; 1998 Nov; 122(11):1010-7. PubMed ID: 9822131 [TBL] [Abstract][Full Text] [Related]
18. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods. Tang LH; Gonen M; Hedvat C; Modlin IM; Klimstra DS Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928 [TBL] [Abstract][Full Text] [Related]
19. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. La Rosa S; Inzani F; Vanoli A; Klersy C; Dainese L; Rindi G; Capella C; Bordi C; Solcia E Hum Pathol; 2011 Oct; 42(10):1373-84. PubMed ID: 21531442 [TBL] [Abstract][Full Text] [Related]
20. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Maru DM; Khurana H; Rashid A; Correa AM; Anandasabapathy S; Krishnan S; Komaki R; Ajani JA; Swisher SG; Hofstetter WL Am J Surg Pathol; 2008 Sep; 32(9):1404-11. PubMed ID: 18670347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]